Skip to main content
Log in

Effects of β-alanine treatment on the taurine and DNA content of the rat heart and retina

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Experimental evidence has suggested that the high endogenous levels of taurine found in the rat heart and retina are maintained to a large extent by transport processes out of the blood, rather than by endogenous biosynthesis. When these high levels are depleted, dysfunction ensues. In vitro studies have shown that β-alanine is a good antagonist of these transport processes. The current studies were done to evaluate the feasibility of depleting heart and retinal taurine levels in vivo through treatment of adult rats either orally or with injections of β-alanine. None of the treatments had significant effects on retinal taurine content; ventricular taurine was reduced in some situations, but the effects were not maintained, nor as large as with another transport antagonist. No functional changes were observed. Oral treatment with β-alanine had fewer obvious side effects than injections, but all treated rats had body weights less than age-matched controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lake, N. 1986. Electroretinographic deficits in rats treated with guanidinoethyl sulfonate, a depletor of taurine. Exp. Eye Res. 42:87–91.

    PubMed  Google Scholar 

  2. Lake, N., and Malik, N. 1987. Retinal morphology in rats treated with a taurine transport antagonist. Exp. Eye Res. 44:331–346.

    PubMed  Google Scholar 

  3. Hayes, K. C., Carey, R. E., and Schmidt, S. Y. 1975. Retinal degeneration associated with taurine deficiency in the cat. Science 188:949–951.

    PubMed  Google Scholar 

  4. Neuringer, M. D., Sturman, J. A., Wen, G. Y., and Wisniewski, H. M. 1985. Dietary taurine is necessary for normal retinal development in monkeys. Pages 53–62,in Oja, S. S., Ahtee, L., Kontro, P., and Paasonen, M. K. (eds.), Taurine: Biological Actions and Clinical Perspectives, Alan R. Liss, New York.

    Google Scholar 

  5. Geggel, S. H., Ament, H. E., Heckenlively, J. R., Martin, D. A., and Kopple, J. D. 1985. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. New Engl. J. Med. 312:142–146.

    PubMed  Google Scholar 

  6. Lake, N., De Roode, M., and Nattel, S. 1987. Effects of taurine depletion on rat cardiac electrophysiology: in vivo and in vitro studies. Life Sciences 40:997–1005.

    PubMed  Google Scholar 

  7. Pion, P. D., Kittleson, M. D., Rogers, Q. R., and Morris, J. G. 1987. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768.

    PubMed  Google Scholar 

  8. Huxtable, R. J. 1976. Metabolism and function of taurine in the heart. Pages 99–119,in Huxtable, R., and Barbeau, A. (eds.), Taurine, Raven Press, New York.

    Google Scholar 

  9. Lake, N. 1981. Depletion of retinal taurine by treatment with guanidinoethyl sulfonate. Life Sciences 29:445–448.

    PubMed  Google Scholar 

  10. Lake, N. 1982. Depletion of taurine in the adult rat retina. Neurochem. Res. 7:1385–1390.

    PubMed  Google Scholar 

  11. Sturman, J. A., and Hayes, K. C. 1980. The biology of taurine in nutrition and development. Adv. Nutr. Res. 3:231–299.

    Google Scholar 

  12. Huxtable, R. J., Laird, H. E., and Lippincott, S. 1979. The transport of taurine in the heart and rapid depletion of tissue taurine content by guanidinoethyl sulfonate. J. Pharmacol. Exp. Ther. 211:465–471.

    PubMed  Google Scholar 

  13. Yates, C., Dewar, A., Wilson, H., Winterburn, A., and Reading, H. 1974. Histological and biochemical studies on the retina of a new strain of dystrophic rat. Exp. Eye Res. 18:119–133.

    PubMed  Google Scholar 

  14. Troll, W., and Cannan, R. 1953, A modified photometric ninhydrin method for the analysis of amino and imino acids. J. Biol. Chem. 200:803–811.

    PubMed  Google Scholar 

  15. Larsen, B. R., Grosso, D. S., and Chang, S. Y. 1980. A rapid method for taurine quantitation using high performance liquid chromatography. J. Chromatographic Science 18:233–236.

    Google Scholar 

  16. Starr, M. S., and Voaden, M. J. 1972. The uptake metabolism and release of14C-taurine by rat retina in vitro. Vis. Res. 12:1261–1269.

    PubMed  Google Scholar 

  17. Shaffer, J. E., and Kocsis, J. J. 1981. Methods of reducing tissue taurine levels. Pages 219–229,in Schaffer, S. W., Baskin, S. I., and Kocsis J. J. (eds.), The Effects of Taurine on Excitable Tissues, Spectrum Publications, New York.

    Google Scholar 

  18. Pasantes-Morales, H., Quesada, O., Carabez, A., and Huxtable, R. J. 1983. Effects of the taurine transport antagonist, guanidinoethane sulfonate, and β-alanine on the morphology of rat retina. J. Neurosci. Res. 9:135–143.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lake, N., De Marte, L. Effects of β-alanine treatment on the taurine and DNA content of the rat heart and retina. Neurochem Res 13, 1003–1006 (1988). https://doi.org/10.1007/BF00970775

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00970775

Key Words

Navigation